|
|
|
|
 |
|
SENSEX
|
 |
48.45
|
0.19%
|
|
25776.00
|
|
|
|
NIFTY
|
 |
78.56
|
0.09%
|
|
83817.69
|
|
|
|
Nasdaq
|
 |
-336.92
|
-1.43%
|
|
23255.19
|
|
|
|
Nikkei 225
|
 |
2065.48
|
3.92%
|
|
54720.66
|
|
|
|
FTSE 100
|
 |
-27.00
|
-0.26%
|
|
10314.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
543245
|
|
ISIN Demat |
INE068V01023
|
|
Book Value (Rs) |
628.70
|
|
|
NSE Code |
GLAND
|
|
Dividend Yield % |
0.95
|
|
Market Cap (Rs) |
311537.92
|
|
|
TTM PE(x) |
26.65
|
|
TTM EPS(Rs) |
70.96
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
20-03 1978
|
|
Registered Office
|
Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District, Hyderabad, Telangana-500043 .
|
|
ISINNO
|
INE068V01023
|
|
Phone
|
040 30510999
|
|
E-mail
|
gland@glandpharma.com / investor@glandpharma.com |
|
URL
|
www.glandpharma.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Srinivas Sadu
|
|
Managing Director
|
|
|
Company Secretary
|
Sampath Kumar Pallerlamudi
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|